Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease in which the right ventricular myocardium is replaced by progressive fibrous adipose tissue. ARVC is clinically characterized by right ventricular enlargement, ventricular arrhythmia, and sudden cardiac death. It eventual...

Full description

Bibliographic Details
Main Authors: Danni Zhou, Yaxun Sun, Jiaxi Shen, Jun Su, Tingyu Gong, Chenyang Jiang, Ping Liang
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S187350612030266X
id doaj-fc64dd670095441da80bc7d1b0009ef1
record_format Article
spelling doaj-fc64dd670095441da80bc7d1b0009ef12020-11-25T01:53:45ZengElsevierStem Cell Research1873-50612020-10-0148101965Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutationDanni Zhou0Yaxun Sun1Jiaxi Shen2Jun Su3Tingyu Gong4Chenyang Jiang5Ping Liang6Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, ChinaKey Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, ChinaKey Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, ChinaKey Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China; Correspondence to: Ping Liang, MD, PhD, 268 Kaixuan Road, North Block of the Central Building, Room 404, Hangzhou 310029, China. Phone: 86 571 86971872.Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China; Correspondence to: Ping Liang, MD, PhD, 268 Kaixuan Road, North Block of the Central Building, Room 404, Hangzhou 310029, China. Phone: 86 571 86971872.Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease in which the right ventricular myocardium is replaced by progressive fibrous adipose tissue. ARVC is clinically characterized by right ventricular enlargement, ventricular arrhythmia, and sudden cardiac death. It eventually leads to heart failure, and thus has a significant impact on the patient's health. In this study, human dermal fibroblasts were obtained from a patient with ARVC, which were subsequently reprogrammed with a non-integrated Sendai virus to generate a patient-specific induced pluripotent stem cell (iPSC) line. The iPSC line exhibited normal karyotype and morphology, expressed pluripotency markers, and was capable of differentiating into three germ layers.http://www.sciencedirect.com/science/article/pii/S187350612030266X
collection DOAJ
language English
format Article
sources DOAJ
author Danni Zhou
Yaxun Sun
Jiaxi Shen
Jun Su
Tingyu Gong
Chenyang Jiang
Ping Liang
spellingShingle Danni Zhou
Yaxun Sun
Jiaxi Shen
Jun Su
Tingyu Gong
Chenyang Jiang
Ping Liang
Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
Stem Cell Research
author_facet Danni Zhou
Yaxun Sun
Jiaxi Shen
Jun Su
Tingyu Gong
Chenyang Jiang
Ping Liang
author_sort Danni Zhou
title Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
title_short Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
title_full Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
title_fullStr Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
title_full_unstemmed Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
title_sort generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a pkp2/c.2489 + 1g > a mutation
publisher Elsevier
series Stem Cell Research
issn 1873-5061
publishDate 2020-10-01
description Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease in which the right ventricular myocardium is replaced by progressive fibrous adipose tissue. ARVC is clinically characterized by right ventricular enlargement, ventricular arrhythmia, and sudden cardiac death. It eventually leads to heart failure, and thus has a significant impact on the patient's health. In this study, human dermal fibroblasts were obtained from a patient with ARVC, which were subsequently reprogrammed with a non-integrated Sendai virus to generate a patient-specific induced pluripotent stem cell (iPSC) line. The iPSC line exhibited normal karyotype and morphology, expressed pluripotency markers, and was capable of differentiating into three germ layers.
url http://www.sciencedirect.com/science/article/pii/S187350612030266X
work_keys_str_mv AT dannizhou generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
AT yaxunsun generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
AT jiaxishen generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
AT junsu generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
AT tingyugong generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
AT chenyangjiang generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
AT pingliang generationofaninducedpluripotentstemcelllinefromthedermalfibroblastsofapatientwitharrhythmogenicrightventricularcardiomyopathycarryingapkp2c24891gamutation
_version_ 1724989216586203136